The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: January 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome

  • 1. Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
  • 2. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation
  • 3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome
  • 4. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
  • 5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer
  • 6. Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
  • 7. Deciphering the immunopeptidome in vivo reveals new tumour antigens
  • 8. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment
  • 9. RASA2 ablation in T cells boosts antigen sensitivity and long-term function
  • 10. Sensitisation of cancer cells to radiotherapy by serine and glycine starvation
Previous
Next

Danenberg, E. et al. Nature Genetics. 54: 660–669 (2022).
doi: 10.1038/s41588-022-01041-y.

Summary of the findings

The functions of the tumour microenvironment (TME) are orchestrated by precise spatial organisation of specialised cells, yet we know very little about the multicellular structures that form within the TME. We systematically mapped TME structures in situ using imaging mass cytometry and multi-tiered spatial analysis of 693 breast tumours linked to genomic and clinical data. We borrowed methods used in the analysis of social networks to discover recurrent spatially conserved orientations of immune and stromal cells (TME structures). We identified 10 recurrent TME structures that varied by vascular content, stromal quiescence versus activation, and leukocyte composition. These TME structures had distinct enrichment patterns among breast cancer subtypes, and some were associated with genomic profiles indicative of immune escape. Regulatory and dysfunctional T cells co-occurred in large ‘suppressed expansion’ structures. These structures were characterized by high cellular diversity, proliferating cells, and enrichment for BRCA1 and CASP8 mutations, and predicted poor outcome in ER-positive disease. The landscape of multicellular structures revealed here links conserved spatial organisation to local TME function and holds potential for better patient stratification. All data have been deposited in the public domain, and should serve as a resource for other studies of the multicellular organisation of breast cancer.

Using imaging mass cytometry and multi-tiered spatial analysis, the landscape of 10 recurrent multicellular structures in the brest tumour microenvironment (TME) was mapped. Correlation with genomic features of the tumours revealed an association of TME features with genomic cancer subtypes and somatic alterations. Correlation with clinical features suggests these TME features are a key determinant of clinical outcome.
Read more in Nature Genetics

 

3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome

  • 1. Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
  • 2. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation
  • 3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome
  • 4. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
  • 5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer
  • 6. Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
  • 7. Deciphering the immunopeptidome in vivo reveals new tumour antigens
  • 8. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment
  • 9. RASA2 ablation in T cells boosts antigen sensitivity and long-term function
  • 10. Sensitisation of cancer cells to radiotherapy by serine and glycine starvation
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

How the EACR Congress inspired translational innovation and the launch of a spin-out company

How the EACR Congress inspired translational innovation and the launch of a spin-out company

May 14, 2026

EACR member Munitta Muthana provides some insight into her team’s experience at EACR 2025 in Lisbon, and how it catalysed the momentum and vision for their...

How Nerves Shape Cancer: From Energy Rewiring to Metastasis – Episode 32 of The Cancer Researcher Podcast

How Nerves Shape Cancer: From Energy Rewiring to Metastasis – Episode 32 of The Cancer Researcher Podcast

May 11, 2026

In recent years, the neuronal component of the cancer microenvironment and the metabolic plasticity of cancer cells have become increasingly recognised as essential for cancer progression....

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: April 2026

April 28, 2026

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

How the EACR Congress inspired translational innovation and the launch of a spin-out company
Career

How the EACR Congress inspired translational innovation and the launch of a spin-out company

May 14, 2026
“This technique is highly complex and would not have been possible to perform in my lab”: María Martínez Fernández’s EACR Travel Fellowship
Community

“This technique is highly complex and would not have been possible to perform in my lab”: María Martínez Fernández’s EACR Travel Fellowship

May 12, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR